Clinical Trial Update: Liothyronine (T3) for Bipolar Depression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Liothyronine (T3) for bipolar depression has completed with results posted in 2015. The sponsor is Northwell Health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Liothyronine (liothyronine)

Snippet

Sponsor: Northwell Health | Conditions: Depression, Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-07-02